Controlled Substances

Medea maintains a comprehensive line of DEA-scheduled controlled substances to meet the needs of government agencies, hospitals, and healthcare partners. Our Schedule II offerings include opioid analgesics such as morphine sulfate, oxycodone, oxymorphone, hydromorphone, hydrocodone-acetaminophen, codeine sulfate, meperidine, levorphanol, and methadone, as well as the stimulant lisdexamfetamine (Vyvanse). Schedule III products include buprenorphine and buprenorphine-naloxone (Subutex®/Suboxone®), testosterone cypionate and topical testosterone, butalbital-acetaminophen-caffeine with codeine (Fioricet® with Codeine), and sodium oxybate (Xyrem®). Our Schedule IV line features benzodiazepines including alprazolam (Xanax®), diazepam (Valium®), and midazolam (Versed®), along with phenobarbital, butorphanol tartrate nasal spray, and zaleplon (Sonata®). As a DEA-licensed distributor, Medea supplies these Schedule II–IV products in strict compliance with federal regulations, supported by secure logistics and our proprietary order-management platform. To place an order or request a product not listed here, please inquire within.